ホーム › 非小細胞肺癌 › カリフォルニア州 › Baldwin Park
Baldwin Park、CAにおける非小細胞肺癌の臨床試験
Baldwin Parkとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する36件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第3相
- City of Hope /ID# 243157, Duarte · 4マイル先
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
被験者募集中第2/3相
- City of Hope National Medical Center /ID# 277005, Duarte · 4マイル先
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- Kaiser Permanente-Baldwin Park, Baldwin Park
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
被験者募集中第1相
- City of Hope National Medical Center, Duarte · 4マイル先
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
被験者募集中第2相
- City of Hope, Duarte · 4マイル先
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
被験者募集中第1相
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
被験者募集中第1相
- City of Hope National Medical Center, Duarte · 4マイル先
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
被験者募集中第1相
- Research Site, Duarte · 4マイル先
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
被験者募集中第2相
- City of Hope, Duarte · 4マイル先
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- City of Hope, Duarte · 4マイル先
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
被験者募集中第1相
- Research Site, Duarte · 4マイル先
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
被験者募集中第1相
- City of Hope Cancer Center, Duarte · 4マイル先
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
被験者募集中第1/2相
- City of Hope - Duarte Cancer Center, Duarte · 4マイル先
A Study of KK2269 in Adult Participants With Solid Tumors
被験者募集中第1相
- City Of Hope National Medical Center, Duarte · 4マイル先
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
被験者募集中第3相
- Research Site, Duarte · 4マイル先
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
被験者募集中第1/2相
- City of Hope, Duarte · 4マイル先
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
被験者募集中第1相
- City of Hope National Medical Center, Duarte · 4マイル先
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
被験者募集中第1/2相
- City of Hope, Duarte · 4マイル先
AOH1996 for the Treatment of Refractory Solid Tumors
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
被験者募集中第1相
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4マイル先
- IP Address: City of Hope Investigational Drug Services(IDS), Duarte · 4マイル先
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
被験者募集中第3相
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy
被験者募集中健康なボランティア歓迎
- City of Hope Medical Center, Duarte · 4マイル先
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
被験者募集中第1/2相
- City of Hope - Duarte, Duarte · 4マイル先
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
被験者募集中第1相
- City of Hope National Medical Center /ID# 276272, Duarte · 4マイル先
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Research Site, Duarte · 4マイル先
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2/3相
- Kaiser Permanente-Baldwin Park, Baldwin Park
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
被験者募集中
- Beckman Research Institute of City of Hope, Duarte · 4マイル先
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer
被験者募集中第1相
- City of Hope Medical Center, Duarte · 4マイル先
Phase II Trial of Lung Chemoemobolization
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
被験者募集中第2相
- City of Hope Medical Center, Duarte · 4マイル先
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Duarte · 4マイル先
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY121件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH57件の研究
- Washington, DC55件の研究
Baldwin Parkにおける他の研究
- 乳がん44件の研究
- 急性骨髄性白血病40件の研究
- 大腸癌37件の研究
- がん（全種類）34件の研究
- 前立腺がん30件の研究
- 転移性癌30件の研究
- 骨髄異形成症候群26件の研究
- 卵巣がん25件の研究
- 肺がん24件の研究
- 多発性骨髄腫23件の研究
- 胃癌22件の研究
- 急性リンパ性白血病21件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。